The OSAsense measurement consists of an overnight oxygen saturation measurement and actigraphy.
To assess the patient's symptoms, we use several internationally validated questionnaires.
OSAsense automatically generates an advisory report based on which the healthcare provider can best help the patient move forward.
A prospectively validated exclusion diagnostic for sleep apnea.
Because patientfriendly OSA exclusion diagnostics makes sense
Overnight screening at home, no hospital visits
OSAsense reduces unnecessary hospital referrals
OSAsense reduces the cost of OSA detection
OSAsense has been clinically validated
Improves collaboration with second- and third-line care centers.
Exciting news! We are proud to announce that OSAsense is CE certified, under the Medical Device Regulation (MDR) (class lla).
What is MDR? The MDR is an EU-wide regulation that standardises and improves safety and performance requirements for medical devices, such as our innovative OSAsense sleep apnoea exclusion diagnostics.
What does this certification mean for us? The Class IIa CE certification means OSAsense has undergone rigorous evaluation and meets the highest quality and safety standards. It allows us to confidently maintain our cutting-edge solution in the European market and enables us to make a significant impact in healthcare.
Big thanks to Evidencio, the incredible team behind this achievement! Evidencio has provided rapid MDR certification in a quick, easy and cost-effective process. The collaboration with Evidencio will ensure that OSAsense can quickly add new indications to its service palette in the same way in the near future.
Read the original post here.
OSAsense, you have once again achieved the ISO 27001 and NEN7510 certifications, confirming our commitment to high quality data security and quality standards in the healthcare sector.
The ISO 27001 certification attests to our robust information security systems, while the NEN7510 certification specifically addresses the healthcare sector, meeting the highest standards for information security and quality management.
These renewed certifications reflect OSAsense's ongoing commitment to protecting health data and maintaining the highest standards in delivering our services. We are proud of this achievement and continue to strive for outstanding data security and quality of care.
Stay tuned for our ongoing efforts to ensure your health and well-being. At OSAsense, we are committed to safety, quality and the best care for you.
In a competition with stiff competition, our own medical director Dr. Rick Pleijhuis captured the title "Healthcare Innovator of the Year 2023" at the Mobile Healthcare Congress, with nearly half of the votes. The award was given for, among other things, his low-threshold and effective approach to measuring sleep apnea using only a watch and finger sensor.
This innovation is based on a smart watch with a special sensor worn on the finger while sleeping. This makes it easier for potential sleep apnea patients to sleep comfortably while the watch collects important data.
What sets OSAsense's solution apart is its practicality. The data collected is used to generate detailed reports, allowing general practitioners to respond quickly and effectively. Whether referring patients to a sleep center or ruling out sleep apnea, Dr. Rick Pleijhuis's innovation provides a useful tool for medical practice.
By winning this award, it underscores the value of Dr. Rick Pleijhuis's contribution to improving healthcare. We congratulate him on this well-deserved recognition and look forward to the continued impact of this practical solution in healthcare.
From July 2023, general practices affiliated with Medrie, regional organization for general practitioners in the Flevoland, Hardenberg and Zwolle regions, can also start using OSAsense.
OSAsense has joined forces with Medrie. Together we are taking an important step forward by jointly offering advanced exclusion diagnostics for sleep apnea.
This strategic partnership combines OSAsense's expertise with Medrie's extensive network in the aforementioned regions. As of July 2023, general practices affiliated with Medrie will have the opportunity to use this innovative exclusion diagnostics, significantly increasing the accessibility of this important service.
This initiative aims not only to exclude sleep apnea, but also to provide practical solutions. GP practices will benefit from the implementation of OSAsense technology, enhancing diagnostic capabilities and ensuring an improved care experience for patients.
The joint commitment of OSAsense and Medrie is a clear manifestation of our shared mission to provide high-quality care and innovative solutions to the communities we serve. We look forward to working together to build a healthier future with prevention and accessibility at its core.
Stay tuned to our joint efforts and find out how OSAsense and Medrie are working together to advance the health and well-being of our communities.
15/01/2025
GP Kasper Veldhuis advocates the use of the OSAsense. It has helped him diagnose common complaints such as fatigue, dyspnoea and palpitations more quickly and make more targeted referrals.
Kasper Veldhuis, a general practitioner in Arnhem, contacted the editors of Huisartsgeneeskunde himself after reading an article on atrial fibrillation, which briefly discussed the increasing attention to the role of sleep apnoea in the development of this cardiac arrhythmia.
Veldhuis, who has extensive experience with the screening tool OSAsense and a keen interest in lung disorders, was keen to explain more about this important topic.
OSAsense is low-threshold and costs little for the GP, while the screening is fully reimbursed by health insurers. Using this tool can lead to faster diagnosis, more effective treatment of sleep apnoea and thus better outcomes for patients with cardiac arrhythmias.
Veldhuis is enthusiastic about the benefits of OSAsense, especially the cost and time savings for both patients and healthcare providers. He expects sleep apnoea screening to play an important role in cardiovascular risk management in primary care.
Click on the link to read more.
21/12/2023
With the OSAS care pathway, as a general practitioner you can rule out that a patient has OSAS (sleep apnea). This is done with a pulse oximetry measurement with the OSAsense watch. The patient does this nocturnal measurement himself in the home setting. In addition, the patient fills out a questionnaire online. Diagnostics via OSAsense is patient-friendly, quick, low-threshold, relatively inexpensive and intended only for exclusion diagnostics. The OSAS care pathway is not a screening: referral to a sleep center remains necessary to demonstrate OSAS.
Read more about OSAsense here in the article written by GHC Groningen.
16/02/2023
The Dokkum GP Center now offers diagnostics for Obstructive Sleep Apnea Syndrome (OSAS) using OSAsense. This service includes a validated online questionnaire and an overnight saturation measurement with a special watch-shaped saturation meter.
The OSAsense algorithm detects sleep apnea with high sensitivity (~100%) and specificity (>70%). By using OSAsense before referring patients to a sleep center, unnecessary and costly investigations can be avoided for low-risk patients, while patients at significant risk can be quickly and effectively referred for diagnosis and treatment. If you experience symptoms such as snoring with breath stops, it is recommended that you make an appointment with your primary care physician.
Read more about OSAsense here in the article written by the Huisartsencentrum Dokkum.